NRX Pharmaceuticals Inc. (NRXP)
NASDAQ · Healthcare
NRX Pharmaceuticals Inc. Shareholder Equity 2023–2025
NRX Pharmaceuticals Inc. annual shareholder equity history from 2023 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- NRX Pharmaceuticals Inc. shareholder equity as of December 31, 2025: -15.9M, a 31.37% decrease year-over-year.
- NRX Pharmaceuticals Inc. shareholder equity for 2025 were -15.9M, a 31.37% decrease from 2024.
- NRX Pharmaceuticals Inc. shareholder equity for 2024 were -23.2M, a 97.93% increase from 2023.
- NRX Pharmaceuticals Inc. shareholder equity for 2023 were -11.7M.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| NRX Pharmaceuticals Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $-16 |
| 2024 | $-23 |
| 2023 | $-12 |
NRX Pharmaceuticals Inc. Shareholder Equity — FAQ
NRX Pharmaceuticals Inc. (NRXP) shareholder equity over the last 3 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see NRXP's shareholder equity history?
The chart and table above show NRX Pharmaceuticals Inc.'s shareholder equity by year and by quarter, including the growth rate.